Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ·Healthcare·Biotechnology
$11.49
-5.67%
Mkt Cap $261.88M
Analyst Ratings
No recent rating data.
Price Target (6 analysts)
$20.00
Range $20.00 – $20.00
Implied Upside
+74.1%
Consensus $20.00 vs current $11.49
NASDAQ·Healthcare·Biotechnology
$11.49
-5.67%
Mkt Cap $261.88M
No recent rating data.
Price Target (6 analysts)
$20.00
Range $20.00 – $20.00
+74.1%
Consensus $20.00 vs current $11.49